Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $18.1300 (1.4%) ($17.5400 - $18.1500) on Wed. Jan. 18, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.49% (three month average) | RSI | 55 | Latest Price | $18.1300(1.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.5% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(61%) IBB(61%) XBI(59%) IWO(56%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -2.245% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-6%) GDXJ(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.245% (StdDev 4.49%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
5 Day Moving Average | $18.36(-1.25%) | 10 Day Moving Average | $18.24(-0.6%) | 20 Day Moving Average | $17.7(2.43%) | To recent high | -3.4% | To recent low | 45.5% | Market Cap | $1.126b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |